山本 真功 やまもと まさのり 先生

来歴等

略歴

2003年 日本医科大学千葉北総病院 研修医
2004年 日本医科大学千葉北総病院 助教
2011年 パリ12大学付属アンリモンドール病院　循環器内科 フェロー
2012年 日本医科大学千葉北総病院 助教
2013年 日本医科大学付属病院 助教
2013年 日本医科大学千葉北総病院 助教
2013年 豊橋ハートセンター　循環器内科
2014年 名古屋ハートセンター　循環器内科 兼任
2020年 岐阜ハートセンター　循環器内科 兼任

論文

• Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.

  Yamamoto M, Otsuka T, Shimura T, Yamaguchi R, Adachi Y, Kagase A, Tokuda T, Yashima F, Watanabe Y, Tada N, Naganuma T, Araki M, Yamanaka F, Mizutani K, Tabata M, Watanabe S, Sato Y, Ueno H, Takagi K, Higashimori A, Shirai S, Hayashida K.Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130. Online ahead of print.

• Percutaneous Aortic Valve Intervention in Patients Scheduled for Noncardiac Surgery: A Japanese Multicenter Study.

  Yamamoto M, Kagase A, Shimura T, Koyama Y, Tsujimoto S, Kano S, Hosoba S, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Hayashida K; OCEAN-TAVI investigators.Cardiovasc Revasc Med. 2020 May;21(5):621-628. doi: 10.1016/j.carrev.2019.09.023. Epub 2019 Oct 22.

• Transcatheter aortic valve replacement outcomes in Japan: Optimized CathEter vAlvular iNtervention (OCEAN) Japanese multicenter registry.

  Yamamoto M, Watanabe Y, Tada N, Naganuma T, Araki M, Yamanaka F, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Shirai S, Hayashida K; OCEAN-TAVI investigators.Cardiovasc Revasc Med. 2019 Oct;20(10):843-851. doi: 10.1016/j.carrev.2018.11.024. Epub 2018 Dec 4.

• Novel proctorship effectively teaches interventionists coronary artery chronic total occlusion lesions.

  Yamamoto M, Tsuchikane E, Kagase A, Shimura T, Teramoto T, Kimura M, Matsuo H, Kawase Y, Suzuki Y, Kano S, Habara M, Nasu K, Kinoshita Y, Terashima M, Matsubara T, Suzuki T.Cardiovasc Revasc Med. 2018 Jun;19(4):407-412. doi: 10.1016/j.carrev.2017.10.015. Epub 2017 Oct 26.

• Prognostic Value of Hypoalbuminemia After Transcatheter Aortic Valve Implantation (from the Japanese Multicenter OCEAN-TAVI Registry).

  Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Sago M, Tsunaki T, Koyama Y, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Watanabe Y, Hayashida K.Am J Cardiol. 2017 Mar 1;119(5):770-777. doi: 10.1016/j.amjcard.2016.11.019. Epub 2016 Dec 2.

• Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation.

  Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Koyama Y, Watanabe Y, Tada N, Takagi K, Araki M, Shirai S, Hayashida K.Int J Cardiol. 2016 Aug 15;217:58-63. doi: 10.1016/j.ijcard.2016.04.185. Epub 2016 May 4.

• Effect of body mass index <20 kg/m(2) on events in patients who underwent transcatheter aortic valve replacement.

  Yamamoto M, Hayashida K, Watanabe Y, Mouillet G, Hovasse T, Chevalier B, Oguri A, Dubois-Randé JL, Morice MC, Lefèvre T, Teiger E.Am J Cardiol. 2015 Jan 15;115(2):227-33. doi: 10.1016/j.amjcard.2014.10.026. Epub 2014 Oct 31.

• Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry.

  Yamamoto M, Mouillet G, Meguro K, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Teiger E; FRANCE-2 Registry Investigators.Ann Thorac Surg. 2014 Jan;97(1):29-36. doi: 10.1016/j.athoracsur.2013.07.100. Epub 2013 Oct 17.

• Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry).

  Yamamoto M, Mouillet G, Oguri A, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Teiger E; FRANCE 2 Registry Investigators.Am J Cardiol. 2013 Dec 15;112(12):1932-7. doi: 10.1016/j.amjcard.2013.08.022. Epub 2013 Sep 21.

• Prognostic value of chronic kidney disease after transcatheter aortic valve implantation.

  Yamamoto M, Hayashida K, Mouillet G, Hovasse T, Chevalier B, Oguri A, Watanabe Y, Dubois-Randé JL, Morice MC, Lefèvre T, Teiger E.J Am Coll Cardiol. 2013 Sep 3;62(10):869-77. doi: 10.1016/j.jacc.2013.04.057. Epub 2013 May 22.

• Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation.

  Yamamoto M, Hayashida K, Mouillet G, Chevalier B, Meguro K, Watanabe Y, Dubois-Rande JL, Morice MC, Lefèvre T, Teiger E.JACC Cardiovasc Interv. 2013 May;6(5):479-86. doi: 10.1016/j.jcin.2013.02.007.

• Identification of high-risk plaques associated with peri-procedural myocardial injury following elective percutaneous coronary intervention: assessment by high-sensitivity troponin-T measurements and optical coherence tomography.

  Yamamoto M, Seino Y, Otsuka T, Kurihara O, Negishi K, Murakami D, Takano M, Mizuno K.Int J Cardiol. 2013 Oct 3;168(3):2860-2. doi: 10.1016/j.ijcard.2013.03.134. Epub 2013 Apr 25.

• Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation.

  Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E.Am J Cardiol. 2013 Jan 1;111(1):94-9. doi: 10.1016/j.amjcard.2012.08.053. Epub 2012 Oct 12.

• Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥90 years versus <90 years.

  Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E.Am J Cardiol. 2012 Oct 15;110(8):1156-63. doi: 10.1016/j.amjcard.2012.05.058.

• The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.

  Yamamoto M, Takano M, Murakami D, Inami T, Kobayashi N, Inami S, Okamatsu K, Ohba T, Ibuki C, Hata N, Seino Y, Jang IK, Mizuno K.Am Heart J. 2011 Jun;161(6):1200-6. doi: 10.1016/j.ahj.2011.03.006. Epub 2011 May 11.

• Comparative angioscopic evaluation of neointimal coverage and thrombus between TAXUS-Express and TAXUS-Liberté stents: is the stent platform type associated with the vascular response?

  Yamamoto M, Takano M, Murakami D, Okamatsu K, Seino Y, Mizuno K.Int J Cardiol. 2010 Dec 3;145(3):587-9. doi: 10.1016/j.ijcard.2010.05.073. Epub 2010 Jul 1.

• Impact of small thrombus formation in restenotic bare-metal stent lesions associated with acute coronary syndrome: identification by optical coherence tomography.

  Yamamoto M, Takano M, Murakami D, Inami T, Kobayashi N, Shirakabe A, Inami S, Okamatsu K, Ohba T, Aoki S, Seino Y, Mizuno K.Int J Cardiol. 2011 Jun 2;149(2):169-173. doi: 10.1016/j.ijcard.2009.12.027. Epub 2010 Jan 13.

• Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.

  Yamamoto M, Okamatsu K, Inami S, Takano M, Yokoyama S, Ohba T, Ibuki C, Hata N, Seino Y, Mizuno K.Am Heart J. 2009 Jul;158(1):99-104. doi: 10.1016/j.ahj.2009.04.016.

• Relationship between thin cap fibroatheroma identified by virtual histology and angioscopic yellow plaque in quantitative analysis with colorimetry.

  Yamamoto M, Takano M, Okamatsu K, Murakami D, Inami S, Xie Y, Seimiya K, Ohba T, Seino Y, Mizuno K.Circ J. 2009 Mar;73(3):497-502. doi: 10.1253/circj.cj-08-0762. Epub 2009 Jan 16.